NTLA-2002 in Adults With Hereditary Angioedema (HAE)
Clinical trial NCT05120830 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05120830
- Sponsor
- Intellia Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-10
- Primary completion
- 2024-04-04
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.